Previous Close | 86.64 |
Open | 87.38 |
Bid | 75.20 x 1000 |
Ask | 0.00 x 800 |
Day's Range | 86.65 - 89.15 |
52 Week Range | 62.11 - 93.98 |
Volume | |
Avg. Volume | 2,237,230 |
Market Cap | 22.639B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.60 (1.80%) |
Ex-Dividend Date | Jun 21, 2024 |
1y Target Est | N/A |
NEW YORK, May 06, 2024--IFF (NYSE: IFF) today announced that Glenn Richter, IFF’s Chief Financial and Business Transformation Officer, plans to retire Dec. 31, 2024 after a three-year tenure with the company. A succession process has been initiated to evaluate internal and external candidates to succeed Richter as CFO.
NEW YORK, May 06, 2024--IFF (NYSE: IFF) reported financial results for the first quarter ended March 31, 2024.
IFF, a global leader in food and beverage, home and personal care and health, will introduce its full suite of plant-based and cellulosic-derived solutions for dietary supplements and over-the-counter (OTC) drugs at Vitafoods Europe 2024. This is the first time IFF Pharma Solutions will showcase its full clean-label portfolio for oral dosage forms at Vitafoods Europe, May 14-16, Geneva, Switzerland, booth E90.